ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 72 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $398,000 | -40.2% | 32,480 | -44.1% | 0.00% | -33.3% |
| Q2 2017 | $666,000 | -30.8% | 58,137 | +25.6% | 0.00% | -25.0% |
| Q1 2017 | $963,000 | -4.0% | 46,284 | -4.0% | 0.00% | 0.0% |
| Q4 2016 | $1,003,000 | -38.4% | 48,221 | -3.0% | 0.00% | -42.9% |
| Q3 2016 | $1,629,000 | +31.3% | 49,699 | 0.0% | 0.01% | +40.0% |
| Q2 2016 | $1,241,000 | +48.8% | 49,699 | +48.0% | 0.01% | +25.0% |
| Q1 2016 | $834,000 | -16.8% | 33,573 | +10.5% | 0.00% | 0.0% |
| Q4 2015 | $1,003,000 | +105.1% | 30,380 | +103.6% | 0.00% | +100.0% |
| Q3 2015 | $489,000 | -30.8% | 14,923 | +11.9% | 0.00% | -33.3% |
| Q2 2015 | $707,000 | +230.4% | 13,339 | +79.9% | 0.00% | +200.0% |
| Q1 2015 | $214,000 | +18.2% | 7,413 | +19.4% | 0.00% | 0.0% |
| Q4 2014 | $181,000 | +129.1% | 6,209 | 0.0% | 0.00% | – |
| Q3 2014 | $79,000 | -35.2% | 6,209 | +2.1% | 0.00% | – |
| Q2 2014 | $122,000 | – | 6,079 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |